butabarbital decreases results of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Coadministration of CYP3A4 inducers may perhaps lower sufentanil levels and efficacy, potentially precipitating withdrawal syndrome in patients who definitely have designed Actual physical dependence to sufentanil.